Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Quantitative Calibration of a Spatial QSP Model Identifies Fibroblast Impact on HCC Immunotherapy

Created on 05 Nov 2025

Authors

Zhang, S., Wang, H., Cho, Y., Wong, W., Yarchoan, M., Jaffee, E. M., Ho, W. J., Kagohara, L. T., Fertig, E. J., Popel, A. S., Deshpande, A.

Abstract

Computational models are increasingly used to predict treatment response and optimize cancer therapy strategies. Among these, quantitative systems pharmacology (QSP) models mechanistically simulate tumor progression and pharmacological interventions, enabling virtual clinical trials, model-informed drug development, and biomarker identification. Coupling QSP with an agent-based model yields a spatial QSP (spQSP) platform that captures tissue-level spatial organization of the tumor microenvironment (TME). However, parameterizing such models to represent tumor biology remains an open problem. In this study, we developed a calibration framework using the Approximate Bayesian Computation - Sequential Monte Carlo (ABC-SMC) approach to calibrate the spQSP model with a combination of clinical and spatial molecular data, reflecting the TME characteristics of human tumors. This calibration framework matches tumor architectures between spQSP model predictions and patient spatial molecular data by fitting statistical summaries of cellular neighborhoods. We demonstrate that model calibration using CODEX data from untreated HCC patients enables prediction of TME spatial molecular states in an independent cohort receiving immune-checkpoint inhibitor (ICI) and tyrosine kinase inhibitor (TKI) combination therapy. Finally, we identify spatial and non-spatial pretreatment biomarkers and assess their predictive power for therapeutic response. This workflow demonstrates how integrating spatial-omics with multiscale mechanistic models enables quantitative calibration, biological insight, and in silico biomarker discovery, providing a framework for personalized cancer therapy across tumor types.

Preprint server: bioRxiv
The authors list and abstract were imported from bioRxiv on 05 Nov 2025.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this preprint? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 37
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement